CURVA™, contains a unique blend of active ingredients designed to assist the major systems used by the body to remove and properly process the liberated lipid material subsequent to ZERONA™™. Once released, the fatty material is absorbed by lymphatic vessels and transported to local lymph nodes, from there the material is eventually released into the circulatory system so that the debris can be processed by the liver. CURVA™ is designed to ensure that the lymphatic and circulatory systems, as well as the liver, are functioning at optimal and beneficial levels. CURVA™ possesses a natural blend of Niacin and Ginkgo Biloba. Niacin is a powerful oxidant that helps support the mitochondria; specifically, helps support the electron transport chain which is the major photochemical target of the ZERONA™™. Ginkgo Biloba is a beneficial vasodilator, increasing blood flow to the area being treated; thus enhancing the transportation of nutrients to the cell promoting a stable intracellular environment. ZERONA™™ uses natural intracellular pathways; therefore, CURVA™ has been designed to promote a stable cell environment to enhance the formation of the transitory pore and the release of the stored fatty molecules.

Also within CURVA™ are the active ingredients Green Tea Extract and LCarnitine, both of which will help in the transportation and breakdown of the fatty debris. The lymphatic system is the vehicle that will drive the movement of the fatty material away from the fat storing cell and towards the closest body of lymph nodes for processing. Lymph nodes posses specialized immunologic cells known as macrophage, which are capable of breaking down cholesterol and triglyceride molecules using special lipases. Green Tea Extract has been proven to promote a healthy and stable immune system and is therefore used in CURVA™ to help with the function of macrophage cell. L-Carnitine is an essential molecule for the transportation of fatty acids into the mitochondria so that fatty-acid oxidation can be carried out, a process very important for the ZERONA™ laser.

Finally, once released from the lymphatic system the fatty components will enter the circulatory system where they will be transported to the liver for processing. CURVA™ was formulated to enhance the transport of the fatty molecules within the circulatory system by increasing the concentration of blood transport molecules known as high-density-lipoproteins (HDL). Ingredients such as niacin and omega-3 fatty acids (EPA/DHA) are in CURVA™ and will increase HDL levels while lowering LDL and VLDL levels. The rise in HDL levels will clear the fatty debris at an accelerated rate improving the results of the ZERONA™. The ZERONA™ promotes an incredible biological response forcing the release of the stored fatty material; however, it is highly dependent on the function of the lymphatic and circulatory systems and the liver. Supplements, although not necessary to demonstrate reductions, can enhance tremendously the results observed following a ZERONA™ treatment. ZERONA™ can change lives; CURVA™ is there to support the change.